After a single oral dose of protein-bound CML (CML-BSA), the postprandial concentration of free CML in plasma (Figure 1C) followed a different pattern than that observed with free CML and free (D2)-CML. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.